Tarsus Cash Per Share from 2010 to 2024
| TARS Stock | USD 33.52 0.10 0.30% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 7.7405256 | Current Value 4.9 | Quarterly Volatility 3.48872367 |
Check Tarsus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tarsus Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 6.8 M or Depreciation And Amortization of 1.2 M, as well as many indicators such as Price To Sales Ratio of 35.81, Dividend Yield of 0.0 or PTB Ratio of 3.17. Tarsus financial statements analysis is a perfect complement when working with Tarsus Pharmaceuticals Valuation or Volatility modules.
Tarsus | Cash Per Share |
Latest Tarsus Pharmaceuticals' Cash Per Share Growth Pattern
Below is the plot of the Cash Per Share of Tarsus Pharmaceuticals over the last few years. It is Tarsus Pharmaceuticals' Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tarsus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 9.20 X | 10 Years Trend |
|
Cash Per Share |
| Timeline |
Tarsus Cash Per Share Regression Statistics
| Arithmetic Mean | 3.07 | |
| Geometric Mean | 1.47 | |
| Coefficient Of Variation | 113.75 | |
| Mean Deviation | 3.03 | |
| Median | 0.55 | |
| Standard Deviation | 3.49 | |
| Sample Variance | 12.17 | |
| Range | 8.2656 | |
| R-Value | 0.80 | |
| Mean Square Error | 4.77 | |
| R-Squared | 0.64 | |
| Significance | 0.0004 | |
| Slope | 0.62 | |
| Total Sum of Squares | 170.40 |
Tarsus Cash Per Share History
About Tarsus Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Tarsus Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Tarsus Pharmaceuticals investors use historical funamental indicators, such as Tarsus Pharmaceuticals's Cash Per Share, to determine how well the company is positioned to perform in the future. Although Tarsus Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Tarsus Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tarsus Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tarsus Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tarsus Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Per Share | 7.74 | 4.90 |
Pair Trading with Tarsus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tarsus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Tarsus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tarsus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tarsus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tarsus Pharmaceuticals to buy it.
The correlation of Tarsus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tarsus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tarsus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tarsus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.